References
- Triantafillidis JK, Nasioulas G, Kosmidis PA. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res. 2009;29:2727–2737.
- Gastrointestinal Tumor Study Group. Adjuvant therapy of colon cancer–results of a prospectively randomized trial. New England J Med. 1984;310:737–743.
- Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet. 1987;1:1303–1306.
- Tang R, Wang JY, Chen JS, et al. Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum. J Am Coll Surg. 1995;180:705–712.
- Nagayoshi K, Ueki T, Nishioka Y, et al. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more. Dis Colon Rectum. 2014;57:467–474.
- Yano H, Saito Y, Kirihara Y, et al. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma. Dis Colon Rectum. 2006;49:1867–1877.
- Chen VW, Hsieh MC, Charlton ME, et al. Analysis of stage and clinical/prognostic factors for colon and rectal cancer from SEER registries: AJCC and collaborative stage data collection system. Cancer. 2014;120:3793–3806.
- Puppa G, Sonzogni A, Colombari R, et al. TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. Arch Pathol Lab Med. 2010;134:837–852.
- Resch A, Langner C. Lymph node staging in colorectal cancer: old controversies and recent advances. Wjg. 2013;19:8515–8526.
- Kawada K, Taketo MM. Significance and mechanism of lymph node metastasis in cancer progression. Cancer Res. 2011;71:1214–1218.
- Huh JW, Kim HR, Kim YJ. Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer. J Gastrointest Surg. 2010;14:1074–1080.
- Greene FL, Stewart AK, Norton HJ. A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg. 2002;236:416–421.
- Lord AC, D'Souza N, Pucher PH, et al. Significance of extranodal tumour deposits in colorectal cancer: a systematic review and meta-analysis. Eur J Cancer. 2017;82:92–102.
- Luchini C, Nottegar A, Pea A, et al. Extranodal extension is an important prognostic parameter for both colonic and rectal cancer. Ann Oncol. 2016;27:955–956.
- Tsutsumi S, Watanabe R, Tabe Y, et al. Extranodal metastasis predicts poor survival in advanced colorectal cancer. Hepatogastroenterology. 2012;59:372–374.
- Aziz S, Wik E, Knutsvik G, et al. Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer. PloS One. 2017;12:e0171853.
- Cheng L, Pisansky TM, Ramnani DM, et al. Extranodal extension in lymph node-positive prostate cancer. Mod Pathol. 2000;13:113–118.
- Kim CW, Kim J, Yeom SS, et al. Extranodal extension status is a powerful prognostic factor in stage III colorectal cancer. Oncotarget. 2017;8:61393–61403.
- Fujii T, Tabe Y, Yajima R, et al. Extracapsular invasion as a risk factor for disease recurrence in colorectal cancer. Wjg. 2011;17:2003–2006.
- Kim H, Rehman A, Chung Y, et al. Clinicopathologic significance of extranodal tumor extension in colorectal adenocarcinoma with regional lymph node metastasis. Gastroenterol Res Pract. 2016;2016: 1.
- Veronese N, Nottegar A, Pea A, et al. Prognostic impact and implications of extracapsular lymph node involvement in colorectal cancer: a systematic review with meta-analysis. Ann Oncol. 2016;27:42.
- Komuta K, Okudaira S, Haraguchi M, et al. Identification of extracapsular invasion of the metastatic lymph nodes as a useful prognostic sign in patients with resectable colorectal cancer. Dis Colon Rectum. 2001;44:1838–1844.
- Choi WH, Kim S, Shen J, et al. Prognostic significance of perinodal extension in gastric cancer. J Surg Oncol. 2007;95:540–545.